GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tenax Therapeutics Inc (FRA:YBO0) » Definitions » Cyclically Adjusted Book per Share

Tenax Therapeutics (FRA:YBO0) Cyclically Adjusted Book per Share : €1,087,060.00 (As of Mar. 2024)


View and export this data going back to 2008. Start your Free Trial

What is Tenax Therapeutics Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Tenax Therapeutics's adjusted book value per share for the three months ended in Mar. 2024 was €5.840. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €1,087,060.00 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Tenax Therapeutics's average Cyclically Adjusted Book Growth Rate was -9.20% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was -4.80% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was -7.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Tenax Therapeutics was 3.70% per year. The lowest was -14.50% per year. And the median was -10.10% per year.

As of today (2024-05-27), Tenax Therapeutics's current stock price is €161.60. Tenax Therapeutics's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was €1,087,060.00. Tenax Therapeutics's Cyclically Adjusted PB Ratio of today is 0.00.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Tenax Therapeutics was 18.90. The lowest was 0.01. And the median was 0.15.


Tenax Therapeutics Cyclically Adjusted Book per Share Historical Data

The historical data trend for Tenax Therapeutics's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tenax Therapeutics Cyclically Adjusted Book per Share Chart

Tenax Therapeutics Annual Data
Trend Apr14 Apr15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 31,455.20 32,731.20 27,575.90 29,604.10 223,052.00

Tenax Therapeutics Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 136,506.00 208,539.00 208,566.00 223,052.00 1,087,060.00

Competitive Comparison of Tenax Therapeutics's Cyclically Adjusted Book per Share

For the Biotechnology subindustry, Tenax Therapeutics's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tenax Therapeutics's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Tenax Therapeutics's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Tenax Therapeutics's Cyclically Adjusted PB Ratio falls into.



Tenax Therapeutics Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Tenax Therapeutics's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book= Book Value per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=5.84/131.7762*131.7762
=5.840

Current CPI (Mar. 2024) = 131.7762.

Tenax Therapeutics Quarterly Data

Book Value per Share CPI Adj_Book
201404 68,975.862 100.023 90,872.687
201407 68,472.727 100.520 89,763.806
201410 69,563.636 100.176 91,507.720
201501 73,736.364 98.604 98,543.133
201504 73,950.000 99.824 97,620.703
201507 69,593.182 100.691 91,078.174
201510 64,729.545 100.346 85,003.682
201603 56,464.773 100.470 74,058.760
201606 51,472.727 101.688 66,702.794
201609 47,276.136 101.861 61,160.499
201612 18,465.909 101.863 23,888.698
201703 14,995.455 102.862 19,210.595
201706 11,394.318 103.349 14,528.428
201709 9,690.909 104.136 12,263.157
201712 8,528.409 104.011 10,805.013
201803 7,130.769 105.290 8,924.590
201806 5,862.637 106.317 7,266.547
201809 4,600.000 106.507 5,691.384
201812 4,366.245 105.998 5,428.100
201903 2,376.883 107.251 2,920.421
201906 1,829.496 108.070 2,230.824
201909 1,409.976 108.329 1,715.151
201912 806.413 108.420 980.132
202003 618.800 108.902 748.779
202006 426.307 108.767 516.489
202009 796.705 109.815 956.034
202012 482.003 109.897 577.965
202103 277.885 111.754 327.671
202106 77.524 114.631 89.119
202109 390.667 115.734 444.817
202112 238.540 117.630 267.228
202203 92.571 121.301 100.565
202206 407.492 125.017 429.524
202209 213.127 125.227 224.274
202212 49.180 125.222 51.754
202303 48.990 127.348 50.694
202306 40.915 128.729 41.884
202309 35.457 129.860 35.980
202312 24.896 129.419 25.349
202403 5.840 131.776 5.840

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Tenax Therapeutics  (FRA:YBO0) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Tenax Therapeutics's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=161.60/1087060
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Tenax Therapeutics was 18.90. The lowest was 0.01. And the median was 0.15.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Tenax Therapeutics Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Tenax Therapeutics's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Tenax Therapeutics (FRA:YBO0) Business Description

Industry
Traded in Other Exchanges
Address
101 Glen Lennox Drive, Suite 300, Chapel Hill, NC, USA, 27517
Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of Pulmonary Hypertension associated with Heart Failure and preserved Ejection Fraction.

Tenax Therapeutics (FRA:YBO0) Headlines

No Headlines